dc.contributor.author
Pinto, Jimy-Jose
dc.contributor.author
Pinazo, Maria-Jesus
dc.contributor.author
Saravia, Jaime
dc.contributor.author
Gainsborg, Ingrid
dc.contributor.author
Magne, Helmut-Ramon
dc.contributor.author
Cuatrecasas Freixas, Miriam
dc.contributor.author
Cortés Serra, Núria
dc.contributor.author
Lozano Beltran, Daniel-Franz
dc.contributor.author
Gascón i Brustenga, Joaquim
dc.contributor.author
Torrico, Faustino
dc.date.issued
2019-06-18T15:12:16Z
dc.date.issued
2019-06-18T15:12:16Z
dc.date.issued
2019-02-07
dc.date.issued
2019-05-27T09:01:52Z
dc.identifier
https://hdl.handle.net/2445/135340
dc.description.abstract
Background: Chagas disease (CD) is endemic in Latin America and particularly
common in Bolivia, but there is little information on the characteristics of
chronic digestive involvement.
Objectives: To determine the prevalence and characterize digestive manifestations
in chronic CD patients in Cochabamba, Bolivia.
Methods: Eighty-five T. cruzi-seropositive individuals with or without digestive
symptoms (G1 group), and fifteen T. cruzi-seronegative patients with similar
digestive symptoms to those seen in CD (G2 group) were included in the study.
All patients underwent a detailed history including past medical history,
epidemiological information, hygiene and dietary habits, a complete physical examination, two serological tests for T. cruzi, video endoscopy, barium swallow,
and barium enema.
Findings: We observed digestive manifestations in T. cruzi seropositive and
seronegative patients. Colonic manifestations were detected in both groups,
highlighting the relevance of other confounder factors in the region. Constipation
was present in 52.9% of G1 patients, 62.4% presented two or more upper
digestive tract symptoms, and 5.9% of them presented esophageal manifestations.
Helicobacter pylori infection was detected in 58.8% of G1 patients, and all
patients presented gastritis on endoscopy.
Conclusions: Prevalence of digestive involvement in CD patients is higher than
expected. However, digestive symptoms are not always caused by T. cruzi
infection and require differential diagnoses.
dc.format
application/pdf
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: http://dx.doi.org/10.1016/j.heliyon.2019.e01206
dc.relation
Heliyon, 2019, vol. 5, num. 2
dc.relation
http://dx.doi.org/10.1016/j.heliyon.2019.e01206
dc.rights
cc by-nc-nd (c) Pinto et al., 2019
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (ISGlobal)
dc.subject
Malaltia de Chagas
dc.subject
Malalties de l'aparell digestiu
dc.subject
Chagas' disease
dc.subject
Digestive system diseases
dc.title
Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion